MTOR and hepatocellular carcinoma: Moreover, upregulated mTORC1 signaling activity plays a pivotal role in HCC, and single mTOR inhibitor or the combination of mTOR inhibitors with other drugs have been used in clinical trials for the treatment of HCC [48].